Oxford spinout: AI imaging for stroke (Brainomix 360 Stroke) and lung fibrosis (e-Lung).
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Series C Oxford-based Brainomix raised a £4.8 million Series C extension led by Parkwalk and Hostplus to bring its AI imaging to the US. | $6.1M |
| Dec 2021 | Series B Brainomix, an Oxford stroke-care AI imaging medtech, raised a GBP 16M Series B co-led by Boehringer Ingelheim Venture Fund and Parkwalk Advisors, with Tencent and Oxford University Innovation Fund. | $21.8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.